142 related articles for article (PubMed ID: 1851298)
1. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components.
Matsukuma A; Enjoji M; Toyoshima S
Pathol Res Pract; 1991 Jan; 187(1):62-7. PubMed ID: 1851298
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
Yamasaki T; Tsuda H; Imazeki N; Matsubara O
Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
[TBL] [Abstract][Full Text] [Related]
3. Invasive ductal carcinoma of the breast with a predominant intraductal component: cooperative clinicopathologic study in seven Japanese centers.
Enjoji M; Matsukuma A; Sakamoto G; Toyoshima S; Hirota T; Wada A; Ishida T; Enomoto K; Koyama H; Yamamoto H
Jpn J Clin Oncol; 1992 Apr; 22(2):84-91. PubMed ID: 1320141
[TBL] [Abstract][Full Text] [Related]
4. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
5. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma.
Imamura H; Haga S; Shimizu T; Watanabe O; Kajiwara T; Aiba M
Br J Cancer; 1999 Jan; 79(1):172-8. PubMed ID: 10408711
[TBL] [Abstract][Full Text] [Related]
9. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of carcinoembryonic antigen in infiltrating duct carcinomas of the breast: correlation with morphofunctional parameters and prognostic significance.
d'Amore ES; Gloghini A; Margallo E; Margiocco M; Nicoló G
Arch Anat Cytol Pathol; 1986; 34(2):89-94. PubMed ID: 3022656
[No Abstract] [Full Text] [Related]
11. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
Sironi M; Cantaboni A
Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
[No Abstract] [Full Text] [Related]
12. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
13. [Morphological diagnosis and prognosis in early ductal breast cancer].
Frank GA; Volchenko NN
Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
15. The comedo subtype of intraductal carcinoma. Cytologic characteristics.
Lilleng R; Hagmar B
Acta Cytol; 1992; 36(3):345-52. PubMed ID: 1316029
[TBL] [Abstract][Full Text] [Related]
16. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
17. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
[TBL] [Abstract][Full Text] [Related]
18. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
19. Relationship between grade of intraductal component of breast cancer within main tumor and extent of intraductal spread in surrounding tissue.
Kurosumi M; Suemasu K; Tabei T; Kuwashima Y; Takeo T; Kusawake T; Higashi Y
Anticancer Res; 1998; 18(4B):2869-73. PubMed ID: 9713477
[TBL] [Abstract][Full Text] [Related]
20. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
Hardman PD; Worth A; Lee U; Baird RM
Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
